Elon Musk recently revealed that he submitted the results of a Magnetic Resonance Imaging (MRI) scan to his company’s AI chatbot, Grok, during a conversation with podcaster Peter Diamandis. Musk, who is the CEO of xAI, stated that neither Grok nor his medical professionals identified any issues in the MRI results.
During the interview, which was posted on social media on March 12, 2024, Musk shared his experience, emphasizing his belief in the potential of AI in enhancing health diagnostics. “I did an MRI recently and submitted it to Grok,” Musk explained. “None of the doctors nor Grok found anything.” While he did not disclose the reasons for undergoing the MRI, his discussion reflects a growing trend among tech leaders who are exploring the intersection of artificial intelligence and healthcare.
AI’s Role in Health Diagnostics
Musk’s endorsement of Grok highlights a broader movement where individuals increasingly turn to AI for second opinions on medical evaluations. This trend has gained traction, particularly in Silicon Valley, where prominent figures such as Sam Altman, CEO of OpenAI, and Peter Thiel are investing substantial resources into research aimed at combating aging and extending human lifespan.
In a related development, Musk encouraged others to utilize Grok for health-related queries. He cited a case involving a Norwegian man who claimed that Grok prompted him to seek further medical attention, leading to the discovery of a potentially life-threatening condition. “Try it!” Musk urged in a post on X, referencing remarks from a February 2025 appearance on Joe Rogan’s podcast, where he expressed confidence in AI’s diagnostic capabilities.
Musk’s comments come amidst rising interest in longevity research, with some experts forecasting that advancements in AI could significantly enhance life expectancy. In 2024, Dario Amodei, CEO of Anthropic, suggested that AI might help double human life expectancy by 2030.
Imagining the Future of Longevity
Despite his enthusiasm for longevity solutions, Musk warned against the idea of true immortality, labeling it “one of the worst curses you could possibly give anyone.” He believes that while the challenges of aging are solvable, the implications of extreme longevity need careful consideration. “I’ve long thought that longevity or semi-mortality is an extremely solvable problem,” he remarked, highlighting his conviction that the biological clock is a tangible issue that can be addressed.
In the same conversation, Diamandis, who co-founded a longevity company called Fountain Life, proposed a collaboration with Musk. Fountain Life offers “AI-guided diagnostics” that test for various biomarkers, aimed at preventing avoidable health crises. The approach includes a comprehensive data upload that encompasses an individual’s genome, imaging, and other health information. Diamandis underscored the importance of proactive health management, citing the untimely death of Apple co-founder Steve Jobs from pancreatic cancer as a cautionary tale against delaying necessary medical interventions.
As the dialogue surrounding AI and health continues to evolve, Musk’s experience underscores a potential shift in how individuals manage their health, integrating technology as a key player in medical diagnostics. The implications of this trend could reshape the future of healthcare, bringing AI further into the realm of personal health management.